NRNathalia de Souza Rodrigues

Nathalia de Souza Rodrigues

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nathalia de Souza Rodrigues has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quality Assessment of Melatonin Supplements Marketed in Brazil: Alarming Discrepancies

    by Elizane Langaro, Nathalia de Souza Rodrigues, Ana Carolina Bertoletti de Marchi, Charise Dallazem Bertol

    Melatonin (MLT) is a hormone naturally produced by the pineal gland at night. It has multifunctional properties, including the regulation of circadian rhythms, antioxidant effects, and potential treatments for insomnia and jet lag. Due to simplified regulatory processes, many supplements may present quality deviations. In Brazil, MLT was recently approved for sale in pharmacies at low dosages. In this study, we analyzed the quality of orodispersible tablets containing 0.21 mg of MLT. Characterization was performed using Fourier‐transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analyses (TGA), and scanning electron microscopy (SEM) with an energy‐dispersive X‐ray spectrometer (EDS). A liquid chromatographic method with ultraviolet detection (LC/UV) was developed and validated, and used to perform the identification, assay, and content uniformity tests of the tablets. FTIR, DSC, and TGA analyses indicated excipient interference. SEM/EDS analysis revealed variations in formulation morphology and the presence of impurities, such as copper. The LC/UV method demonstrated precision, accuracy, and linearity, with a limit of detection (LOD) of 1.19 μg/mL and a limit of quantification (LOQ) of 3.98 μg/mL. Excipients and potential adulterants did not interfere with the specificity. Tablet weights ranged from 79 mg to 200 mg. The samples failed both the assay and content uniformity tests, with values ranging from 43% to 75% and from 30% to 78%, respectively. The low active ingredient content significantly compromises efficacy. These findings reinforce the need for standardization and increased regulatory oversight of dietary supplements to ensure efficacy and consumer safety.


  • Psicobióticos no tratamento da depressão e ansiedade

    by Gabriele Luiza Alba, Vitória Citolin Crestani, Charise Dallazem Bertol, Tatiana Staudt, Ana Caroline Tissiani, Nathalia De Souza Rodrigues

    Objetivo: verificar a eficácia dos psicobióticos, um tipo de probiótico, no tratamento da depressão e da ansiedade, considerando a conexão entre o sistema nervoso e a microbiota intestinal. Métodos: foi realizada uma revisão sistemática, incluindo estudos de coorte e ensaios clínicos que avaliaram o uso de probióticos no tratamento desses transtornos. Resultados e Discussão: a análise incluiu 15 artigos. Os resultados indicaram que 100% dos indivíduos com depressão e ansiedade melhoraram seus sintomas. Além disso, 60% dos participantes com apenas ansiedade e 72,7% daqueles com apenas depressão também apresentaram melhorias. A maioria dos estudos teve baixo risco de viés, confirmando os benefícios dos psicobióticos. Conclusão: este estudo reforça a eficácia dos psicobióticos, destacando Bifidobacterium longum e Lactobacillus acidophilus, no tratamento da depressão e da ansiedade, ressaltando o papel do eixo intestino-cérebro. Ainda são necessárias mais pesquisas para confirmar esses achados.

  • Open Access

    In vitro evaluations of warfarin tablets available in the brazilian market

    by Isabela Barbosa, Vitória Crestani, Nathalia de Souza Rodrigues, Tatiana Staudt, Ana Luisa Sant' Anna Alves, Charise Bertol

    The aging of the population has led to an increased use of anticoagulants such as sodium warfarin. This study evaluated the quality of 5 mg warfarin tablets by analyzing eight samples (A1–A8) in accordance with the Brazilian Pharmacopoeia, with the objective of identifying quality deviations and verifying their interchangeability with the referencemedication.The samples were subjected to the following quality control tests: average weight, friability (loss <1.5%), disintegration (within 30 minutes), dosing(content between 92.5% and 107.5%), and content uniformity (acceptance value <15). However, sample A3 failed the dissolution test, releasing less than 40% of the active ingredient within 30 minutes.The equivalence assessment indicated that samplesA1xA2 (69.97) and A1xA4 (54.43) were interchangeable, whereas samples A3, A5, A6, A7, and A8 were not.The comparison of dissolution profiles using the similarity factor (f₂) revealed that several samples exhibited quality deviations, potentially compromising treatment efficacy and safety, and suggesting deficiencies in Good Manufacturing Practices (GMP).